论文部分内容阅读
目的:探讨不同方法对剖宫产后瘢痕子宫中期妊娠(孕14~27周)引产的临床效果。方法:对97例既往有剖宫产史、要求引产的中期妊娠妇女进行回顾性分析,其中单独使用利凡诺的有27例,米非司酮联合利凡诺的有28例,利凡诺联合米索前列醇的有19例,米非司酮联合米索前列醇的有23例,观察采用不同引产方法的孕妇宫缩出现时间、产程、产后出血量及完全流产率的不同。结果:使用米非司酮联合利凡诺、利凡诺联合米索前列醇、米非司酮联合米索前列醇的患者较单独使用利凡诺的患者,其宫缩出现时间及产程均显著性降低,完全流产率均显著性升高,差异有统计学意义(P<0.05)。结论:米非司酮联合利凡诺、利凡诺联合米索前列醇、米非司酮联合米索前列醇优于单独使用利凡诺进行引产,其宫缩时间及产程均降低,完全流产率升高,值得在临床上推广使用。
Objective: To explore the clinical effects of different methods on induction of labor after cesarean section scar pregnancy (14 ~ 27 weeks pregnant). Methods: A retrospective analysis was performed on 97 pregnant women with history of cesarean section and requiring induction of labor. There were 27 cases of rivanol alone, 28 cases of mifepristone and rivanol, There were 19 cases of combined misoprostol, mifepristone combined with misoprostol in 23 cases, observed the use of different induction methods of pregnant women, the occurrence of contractions time, labor, postpartum hemorrhage and complete abortion rate difference. RESULTS: Patients treated with mifepristone combined with rivanol, rivanol combined with misoprostol, and mifepristone combined with misoprostol had significantly shorter contractions and longer duration of labor than those treated with rivanol alone Sexual decline, complete abortion rate were significantly increased, the difference was statistically significant (P <0.05). CONCLUSION: Mifepristone combined with rivanol, rivanol combined with misoprostol and mifepristone combined with misoprostol is superior to rivanol alone in inducing labor, with reduced uterine contractions and labor, and complete abortion The rate of increase, it is worth to promote the clinical use.